Dr. med. Jörn Christian Albring
Assistenzarzt
T 0251 83-52807
F 0251 83-52804
joernchristian.albring(at)ukmuenster(dot)de
AG Albring - Allo-Immunregulation
Unsere Forschung
Unser Team

Dr. med. Jörn Christian Albring
Assistenzarzt
T 0251 83-52807
F 0251 83-52804
joernchristian.albring(at)ukmuenster(dot)de

Prof. Dr. med. Matthias Stelljes
Bereichsleiter allogene zelluläre Immuntherapie
Facharzt für Innere Medizin, Hämatologie und Internistische Onkologie
T 0251 83-52807
F 0251 83-52804
Matthias.Stelljes(at)ukmuenster(dot)de

Dr. rer. nat. Karin Frebel wissenschaftliche Mitarbeiterin T 0251 83-52826
karin.frebel(at)ukmuenster(dot)de

Dr. rer. nat. Stella Robert wissenschaftliche Mitarbeiterin T 0251 83-52822
stella.robert(at)ukmuenster(dot)de

Pia Le
Technische Assistentin
T 0251 83-52821
piahieule(at)ukmuenster(dot)de
piahieule(at)ukmuenster(dot)de
Anika Wohlgemuth
(AG Prof. Stelljes)
Technische Assistentin
Tel.: 0251/83-52821
email: Anika.Wohlgemuth(at)ukmuenster(dot)de
Ausgewählte Publikationen

Robert S*, Albring JC*, Frebel K*, Opitz C, Urh J, Wolf C, Heinrich C, Berdel WE, Stelljes M. Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2018 Jan 23. doi: 10.1038/s41409-017-0071-7. *equal first authors

Albring JC, Inselmann S, Sauer T, Schliemann C, Altvater B, Kailayangiri S, Rössig C, Hartmann W, Knorrenschild JR, Sohlbach K, Groth C, Lohoff M, Neubauer A, Berdel WE, Burchert A, Stelljes M.PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation. Bone Marrow Transplant. 2017;52(2):317-20.

Wu X, Briseno CG, Durai V, Albring JC, Haldar M, Bagadia P, Kim KW, Randolph GJ, Murphy TL, Murphy KM. Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells.J Exp Med. 2016;213(12):2553-65.

Grajales-Reyes GE, Iwata A, Albring J, Wu X, Tussiwand R, Kc W, Kretzer NM, Briseño CG, Durai V, Bagadia P, Haldar M, Schönheit J, Rosenbauer F, Murphy TL, Murphy KM. Batf3 maintains autoactivation of Irf8 for commitment of a CD8alpha(+) conventional DC clonogenic progenitor.Nat Immunol. 2015;16(7):708-17.

Kc W, Satpathy AT, Rapaport AS, Briseno CG, Wu X, Albring JC, Russler-Germain EV, Kretzer NM, Durai V, Persaud SP, Edelson BT, Loschko J, Cella M, Allen PM, Nussenzweig MC, Colonna M, Sleckman BP, Murphy TL, Murphy KM. L-Myc expression by dendritic cells is required for optimal T-cell priming. Nature. 2014;507(7491):243-7.

Tussiwand R, Lee WL, Murphy TL, Mashayekhi M, Kc W, Albring JC, Satpathy AT, Rotondo JA, Edelson BT, Kretzer NM, Wu X, Weiss LA, Glasmacher E, Li P, Liao W, Behnke M, Lam SS, Aurthur CT, Leonard WJ, Singh H, Stallings CL, Sibley LD, Schreiber RD, Murphy KM. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature. 2012;490(7421):502-7.

Satpathy AT, Kc W, Albring JC, Edelson BT, Kretzer NM, Bhattacharya D, Murphy TL, Murphy KM. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med. 2012;209(6):1135-52.

Albring JC, Sandau MM, Rapaport AS, Edelson BT, Satpathy A, Mashayekhi M, Lathrop SK, Hsieh CS, Stelljes M, Colonna M, Murphy TL, Murphy KM. Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression.J Exp Med. 2010;207(12):2551-9.

Stelljes M*, Hermann S*, Albring J*, Kohler G, Loffler M, Franzius C, Poremba C, Schlösser V, Volkmann S, Opitz C, Bremer C, Kucharzik T, Silling G, Schober O, Berdel WE, Schäfers M, Kienast J. Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography.Blood. 2008;111(5):2909-18. *equal first authors

Satpathy AT, Wu X, Albring JC, Murphy KM. Re(de)fining the dendritic cell lineage. Nat Immunol. 2012;13(12):1145-54.